Provenge

Yet Another Group Sues Medicare Over Provenge
Pharmalot
Thu, 01/6/11 - 01:16 pm
Medicare
Provenge
Dendreon
prostate cancer
Director Of Equity Research At RBC Capital Markets Covers Phase III Data For Multiple New Drugs; Find Out The Stocks That Investors Should Look At
Yahoo/Wall Street Transcript
Sat, 12/18/10 - 12:24 pm
Athenahealth
Abbott Laboratories
Beckman Coulter
Agilent
AstraZeneca
Provenge
Dendreon
Benlysta
Human Genome Sciences
Telaprevir
Vertex Pharmaceuticals
Biotech Calendar: FDA Drug Approvals in 2011
TheStreet.com
Mon, 12/13/10 - 12:26 pm
MannKind
Afrezza
Alimera
pSivida
Seattle Genetics
brentuximab vedotin
Illuvien
AstraZeneca
Zictifa
Clinical Data
Vilazodone
Orexigen
Contrave
Bristol-Myers Squibb
Yervoy
Pfizer
Protalix BioTherapeutics
UPLYSO
Xiafaxan
Salix
Human Genome Sciences
Benlysta
Dendreon
Provenge
InterMune
Esbriet
Cell Therapeutics
pixantrone
Forest Labs
Daxas
MELA Sciences
MelaFind
XenoPort
GSK
Horizant
Spectrum Pharmaceuticals
Fusilev
Adventrx
Vertex Pharmaceuticals
Telaprevir
ImmunoCellular Therapeutics (IMUC) : At the Forefront of Targeting Cancer Stem Cells (II)
Wed, 12/1/10 - 04:26 pm
ImmunoCellular
cancer stem cells
Provenge
ICT-107
investors
Dendreon Gains on U.S. Panel’s Backing for Provenge Cancer Drug
Bloomberg
Thu, 11/18/10 - 09:36 am
Dendreon
prostate cancer
Provenge
Summary Box: Medicare advisers say $93,000 cancer drug Provenge helps patients live longer
Yahoo/AP
Wed, 11/17/10 - 06:26 pm
Provenge
Dendreon
vaccines
prostate cancer
Provenge & The Medicare Meeting: Sean Tunis Explains
Pharmalot
Mon, 11/15/10 - 10:55 am
Provenge
Medicare
prostate cancer
Dendreon
Dendreon trades higher on prostate drug review
Yahoo/AP
Thu, 11/11/10 - 05:47 pm
Dendreon
Provenge
vaccines
prostate cancer
Dendreon Data Are Merely Moderate, But Stock Surges Anyway
Forbes
Thu, 11/11/10 - 09:00 am
Provenge
vaccines
Dendreon
prostate cancer
Dendreon's Dilemma Isn't Provenge Competition, Demand -- It's Geography
Minyanville
Mon, 11/8/10 - 10:40 am
Provenge
Dendreon
vaccines
prostate cancer
Are Monthly Numbers Necessary, Dendreon?
Motley Fool
Thu, 11/4/10 - 09:58 pm
Dendreon
Provenge
prostate cancer
Dendreon: Provenge Sales, Guidance Fall Short
TheStreet.com
Wed, 11/3/10 - 06:57 pm
Dendreon
earnings
Provenge
Is Provenge The Most Important Medicine In Biotech?
Forbes
Sat, 10/30/10 - 12:27 pm
Provenge
Dendreon
prostate cancer
ImmunoCellular Therapeutics Optimizes New Manufacturing Method for Novel Cancer Vaccine
Wed, 10/13/10 - 08:42 am
ImmunoCellular
oncology
cancer vaccines
Provenge
For Dendreon’s Provenge, a New Competitor Looms
WSJ Online
Tue, 10/12/10 - 11:07 am
Dendreon
Provenge
prostate cancer
abiraterone
JNJ
Dendreon in Neutral Lane
Yahoo/Zacks.com
Thu, 09/30/10 - 11:23 am
Dendreon
Provenge
Here’s What Medicare Will Ask About Provenge
Pharmalot
Tue, 09/28/10 - 07:47 am
Medicare
Dendreon
Provenge
prostate cancer
AstraZeneca Prostate Cancer Drug Fails
TheStreet.com
Mon, 09/27/10 - 10:40 am
prostate cancer
AstraZeneca
zibotentan
Dendreon
Provenge
$93,000 cancer drug: How much is a life worth?
Yahoo/AP
Sun, 09/26/10 - 12:27 pm
Provenge
Dendreon
Revlimid
Celgene
J&J Expands Options For Prostate Cancer
Yahoo/Investor's Business Daily
Sat, 09/25/10 - 12:08 pm
JNJ
prostate cancer
abiraterone
Provenge
Dendreon

Pages